← Return to Anyone on Fruquintinib?

Discussion

Anyone on Fruquintinib?

Colorectal Cancer | Last Active: Mar 7 6:22pm | Replies (5)

Comment receiving replies
@jmeath

Yes, he started out stage 3 in 2018, had resection surgery & ended up with a colostomy bag. The cancer moved to his lung after a year, he had the spot removed. A mass was spotted on his spine/tailbone a year after that. They tried to remove it, but he almost bled out. He's also had both his prostate and bladder removed leaving him with a urostomy bag.
His first chemo treatment was Folfox/5FU, he almost died after the first dose. He did a radiation and oxaliplatin combo for a while. He switched to IROX plus more radiation with no luck. He recently ended the Lonsurf and Avastin combo. He just hasn't seen any significant results.
I guess the drug Fruqunitinib was recently FDA approved in November of 2023, it's specifically for colorectal cancers, a new doctor on his team suggested it.
I guess we were hoping to get more information from someone who has already started it.

Jump to this post


Replies to "Yes, he started out stage 3 in 2018, had resection surgery & ended up with a..."

Thank you for offering those details of a horribly sad five years that your husband has endured and survived. It is truly an amazing story of the human cruelty that cancer imposes.
May he receive the blessing of a medical miracle in recovery!

@jmeath
It’s hard to imagine feeling hopeful on such a painful difficult road, so kudos for you both for looking forward!
My brother-in-law has been sending me links to that drug plus a promising vaccine in trial stages.
The first 2 links are for that specific drug, the 3rd is to another that might be helpful. It sounds like your team is very aware of all the new trials and studies for mcrc, and I hope they find something that really helps!😘💗🌹
https://www.takedaoncology.com/news/news-releases/Takeda-Receives-US-FDA-Approval-of-FRUZAQLA-fruquintinib-for-Previously-Treated-Metastatic-Colorectal-Cancer/
———
https://www.cancernetwork.com/view/fruquintinib-combo-improves-quality-adjusted-survival-in-metastatic-crc
———-
https://www.fiercepharma.com/pharma/asco-merck-s-keytruda-doubles-time-to-disease-progression-certain-colorectal-cancer-patients